Login / Signup

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study.

Andrew P McGovernJohn M DennisBeverley M ShieldsAndrew T HattersleyEwan R PearsonAngus G Jonesnull null
Published in: BMC medicine (2019)
Where glucose-lowering therapy does not appear effective on initial HbA1c testing, changing agents does not improve glycemic control. The initial agent should be continued with another therapy added.
Keyphrases
  • glycemic control
  • type diabetes
  • blood glucose
  • weight loss
  • cardiovascular disease
  • mesenchymal stem cells
  • stem cells
  • bone marrow
  • skeletal muscle